standard-title
Alzheimer’s Disease
Latest News Regarding Alzheimer’s Disease and Your Health
Loading…
Gum disease is common and unpleasant, but, according to a growing body of evidence, it could also play a role in a surprising range of seemingly unrelated health problems. Cleaning your teeth may be even more important than you thought. Plaque — a sticky substance that contains bacteria — builds up on teeth. If it is not brushed away, the bacteria can irritate the gums. The gums may then become swollen, sore, or infected; this is referred to as gingivitis. In general, gum disease can be treated or prevented by maintaining a good oral health regime. However, if it is left to develop, it can result in periodontitis, which weakens the supporting structures of the teeth. Gum disease, which is also called periodontal disease, is widespread. According to the Centers for Disease Control and Prevention (CDC), almost half of adults in the United States have some degree of gum disease. The mechanisms behind periodontal disease are relatively well-understood, and newer research shows that this health problem may play a role in the development of a number of other conditions, including Alzheimer’s disease, cancer, and respiratory disease. In this Spotlight, we will cover some of the surprising links between gum disease […]
Dementia and Alzheimer’s disease are similar but not the same. Dementia is a general term and has many different types, of which Alzheimer’s is one. There is sometimes confusion between the two because people often use the terms interchangeably. Dementia is an umbrella term used to describe a set of symptoms that broadly affect cognitive functioning, including: memory thinking and focus problem solving language visual perception Alzheimer’s disease is a specific type of dementia that causes a gradual decline in memory and thinking. What is dementia? Some dementia symptoms can be mild and difficult to detect. Dementia is a syndrome, which means that it describes a collection of symptoms with no specific cause. A syndrome is different from a disease, which has specific symptoms and a common cause. Dementia can affect a wide range of mental functions. As a result, many different diseases and conditions are types of dementia. Alzheimer’s disease is the most common form of dementia, but there are several other types, including: vascular dementia, which results from strokes or other conditions that block blood flow to the brain Lewy body dementia, which is a result of abnormal protein deposits in the brain frontotemporal disorders, which are types […]
Latest Alzheimer’s News WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The polar vortex that has enveloped much of the United States this week poses a special danger to people with Alzheimer’s disease and other types of dementia. “This type of weather can be hazardous for everyone, but even more so for individuals living with Alzheimer’s disease, who may have difficulty noticing temperature and weather changes or knowing who to call for help,” said Charles Fuschillo Jr., CEO and president of the Alzheimer’s Foundation of America. “A few easy steps can go a long way to help family caregivers keep their loved one with Alzheimer’s disease safe,” he added in a foundation news release. It’s important for family members and caregivers to know the signs of hypothermia. Be alert for shivering, exhaustion, sleepiness, slurred speech, memory loss and clumsy motor skills, the foundation advised. Caution is needed when using electric space heaters. They can pose a fire risk, especially when used with extension cords or if they get knocked over. For Alzheimer’s or dementia patients, use space heaters that automatically turn off when they reach a set temperature or tip over, the foundation said. Don’t use electric blankets to keep people […]
An Alzheimer’s diagnosis often relies on signs of memory problems. However, these issues usually do not appear until years after the disease has taken hold. A new smartphone game is using spatial navigation to detect Alzheimer’s before it is too late. A simple game that people can play on their smartphones could help detect Alzheimer’s risk. Another person develops Alzheimer’s disease every 3 seconds, according to Alzheimer’s Disease International. The number of people living with this most common form of dementia currently stands at around 50 million. By 2050, experts expect this figure to have tripled. The last “significant breakthrough” in Alzheimer’s research happened 4 decades ago, states the latest World Alzheimer’s Report. However, a recently developed smartphone game may alter that statistic. “Research shows us that the brain changes associated with diseases like Alzheimer’s begin decades before symptoms like memory loss start,” says Hilary Evans, chief executive at Alzheimer’s Research United Kingdom. “[F]or future Alzheimer’s treatments to be effective, it’s likely they must be given at the earliest stages of disease, before there’s too much damage to the brain.” Navigating space A collaboration between the organization, the University of East Anglia (UEA) and University College London in the U.K., […]
Latest Alzheimer’s News WEDNESDAY, July 31, 2019 (HealthDay News) — Even mild anemia — low levels of hemoglobin in the blood — may raise a person’s odds for Alzheimer’s disease and other types of dementia, a new study finds. The same Dutch research also found a correlation between heightened dementia risk and high blood levels of hemoglobin. “With around 10% of people over age 65 having anemia in the Americas and Europe, and up to 45% in African and southeast Asian countries, these results could have important implications for the burden of dementia,” noted study lead author M. Arfan Ikram, of Erasmus Medical Center in Rotterdam, the Netherlands. Hemoglobin is the protein in red blood cells that transports oxygen. The new study included more than 12,000 people averaging 65 years of age. None of the participants had dementia at the beginning of the research. Hemoglobin levels were measured at the start of the study and 6% of the participants were found to have anemia. The participants’ health was then tracked for an average of 12 years. During that time, 1,520 developed dementia, including 1,194 who were diagnosed with Alzheimer’s disease, according to the report published online July 31 in Neurology. […]
A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat or cure Alzheimer’s disease and other serious conditions, the U.S. Food and Drug Administration says. Latest Alzheimer’s News The agency said it posted 12 warning letters and five online advisory letters to U.S. and foreign companies illegally selling more than 58 products, many of which are marketed as dietary supplements. The products — which include tablets, capsules and oils and are often sold on websites and social media — have not been reviewed by the FDA and may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment, according to the FDA The companies have 15 days to respond to the FDA and outline how they intend to correct the violations. Product seizures and/or injunctions are among the actions the FDA could take if the violations are not corrected. “Science and evidence are the cornerstone of the FDA’s review process and are imperative to demonstrating medical benefit, especially when a product is marketed to treat serious and complex diseases like Alzheimer’s,” FDA Commissioner Dr. Scott Gottlieb said in an agency news release. “Alzheimer’s is a […]
Scientists have uncovered a mechanism through which a toxic brain protein that is a hallmark of Alzheimer’s disease can damage neurons, or brain cells. New research uncovers the mechanism that leads to the progressive loss of brain cells that characterizes Alzheimer’s disease. The team at the Grenoble Institute of Neurosciences in France that made the discovery also suggests a potential way to disarm the mechanism during the early stages of the disease. The study concerns the functioning of dendritic spines, which are the tiny structures in the branching parts of brain cells that receive signals from other brain cells. It appears that beta-amyloid, a toxic protein that builds up in the brains of people with Alzheimer’s disease, triggers a mechanism that disrupts the functioning of dendritic spines. The mechanism disables a protein called cofilin 1, and the activity of this protein is crucial for the healthy functioning of dendritic spines. The Journal of Neuroscience has recently published a study paper on the research. It describes how the team used brain tissue samples from mouse models and people with Alzheimer’s disease to arrive at their findings. A key finding was that exposure to beta-amyloid peptides, which are the building blocks of […]
Latest Alzheimer’s News MONDAY, Aug. 12, 2019 (HealthDay News) — If you often find yourself dosing off during the day, new research suggests it might be an early warning sign that you have Alzheimer’s disease. Areas of the brain that keep you awake during the day are damaged in the early stages of the memory-robbing disease, which is why people with Alzheimer’s may nap excessively long before they start to struggle with forgetting things, the study authors said. Not only that, the scientists also found that damage to brain regions involved in daytime wakefulness was caused by a protein called tau. This provides more evidence that tau may play a larger role in Alzheimer’s than the more extensively studied amyloid protein, the researchers noted. “Our work shows definitive evidence that the brain areas promoting wakefulness degenerate due to accumulation of tau — not amyloid protein — from the very earliest stages of the disease,” said study senior author Dr. Lea Grinberg. She is an associate professor of neurology and pathology at the Memory and Aging Center and a member of the Global Brain Health Institute at the University of California, San Francisco (UCSF). Previous research has suggested that excessive napping […]
Latest Alzheimer’s News TUESDAY, April 2, 2019 (HealthDay News) — Brain scans can improve diagnosis and management of Alzheimer’s disease, a new study claims. Researchers assessed the use of PET scans to identify Alzheimer’s-related amyloid plaques in the brain. The study included more than 11,000 Medicare beneficiaries with mild thinking impairment or dementia of uncertain cause. This scanning technique changed the diagnosis of the cause of mental impairment in more than one-third of the participants in the study. The brain scan results also changed management — including the use of medications and counseling — in nearly two-thirds of cases, according to the study published April 2 in the Journal of the American Medical Association. “These results present highly credible, large-scale evidence that amyloid PET imaging can be a powerful tool to improve the accuracy of Alzheimer’s diagnosis and lead to better medical management, especially in difficult-to-diagnose cases,” said study co-author Maria Carrillo, chief science officer of the Alzheimer’s Association. “It is important that amyloid PET imaging be more broadly accessible to those who need it,” she added in an association news release. Funding for the study came from Avid Radiopharmaceuticals Inc., General Electric Healthcare, and Life Molecular Imaging. “We are […]
Researchers found that using a computer, playing games, and participating in social activities may reduce the risk of mild cognitive impairment. New research suggests that playing games, using a computer, and having a rich social life can keep mild cognitive impairment at bay. Our brains go through changes as we get older, and some people may experience issues with memory, thinking, or judgment. Mild cognitive impairment (MCI) is the stage between age-related cognitive decline and dementia — however, MCI does not significantly affect daily life and activities. People with MCI tend to forget things, lose their train of thought or the thread of conversations, and feel overwhelmed by making decisions. According to the Centers for Disease Control and Prevention (CDC), more than 16 million people in the United States are living with cognitive impairment. MCI may increase the risk of dementia, but not everyone with MCI goes on to develop the condition. To date, the Food and Drug Administration (FDA) have not approved any treatments specifically for MCI. Lifestyle choices such as physical exercise and intellectual stimulation have positive effects on the brain. In recent years, researchers have been conducting more studies to find treatments that may prevent cognitive decline. […]
Alzheimer’s disease is a form of neurocognitive decline that affects millions across the world. The exact cause is unclear, but new research is uncovering the mechanisms that allow Alzheimer’s to become established in the brain. Which brain cells are the most vulnerable to Alzheimer’s? In Alzheimer’s disease, as in other forms of dementia, a defining feature is the accumulation of certain toxic proteins in the brain. These proteins aggregate into plaques that disrupt the communication between brain cells, thus enhancing cognitive problems and other issues. More often than not, researchers identify the protein beta-amyloid as the main culprit in this disruptive process. However, another protein, called tau, is just as important. In a new study, researchers from a series of academic institutions, including the Ohio State University in Columbus, Columbia University Medical Center in New York, NY, and Cambridge University in the United Kingdom, have found that tau accumulates preferentially around a specific type of brain cell. The investigators also revealed that certain genetic profiles may predispose a person to tau aggregations around those cells. Co-lead author of the study Hongjun (Harry) Fu — now an assistant professor in the Department of Neuroscience at Ohio State University — and colleagues […]
The results of a new study suggest that virtual reality could make life easier for people with dementia. The authors conclude that virtual reality helped the participants recall memories and contributed to an improvement in patients’ relationships with caregivers. Could virtual reality enhance the lives of people with dementia? Dementia is an umbrella term for a range of conditions, including Huntington’s and Alzheimer’s diseases. It can cause memory loss so severe that it negatively impacts a person’s ability to perform day-to-day activities. A person’s risk of dementia increases as they get older, and a person can be more prone to developing Alzheimer’s based on their ethnicity. For instance, according to the Centers for Disease Control and Prevention (CDC), African Americans are the group most at risk for Alzheimer’s among seniors, followed by Hispanic people, then non-Hispanic white people. The CDC state that the greatest increase in Alzheimer’s disease over the coming decades will occur among Hispanic and African American people and that these increases are largely due to people living longer, as the rates of people dying from chronic diseases are decreasing. Virtual environments triggered memories In the current study, the researchers — many from the University of Kent in […]
New research finds that a 6-month regimen of aerobic exercise can reverse symptoms of mild cognitive impairment in older adults. Just 6 months of exercise that raises the heart rate can reverse signs of age-related cognitive impairment. Mild cognitive impairment (MCI) is characterized by a mild loss of cognitive abilities, such as memory and reasoning skills. A person with MCI may find it hard to remember things, make decisions, or focus on tasks. While the loss of cognitive abilities is not serious enough to interfere with daily activities, MCI raises the risk of Alzheimer’s disease and other forms of dementia. According to the Alzheimer’s Association, 15–20 percent of adults aged 65 and over in the United States have MCI. New research suggests that there might be a way to reverse these age-related cognitive problems. James A. Blumenthal, Ph.D. — of Duke University Medical Center in Durham, NC — and colleagues examined the effects of regimented exercise in 160 people aged 65 on average. They published their findings in the journal Neurology. Studying exercise, diet, and MCI The participants included in the research were sedentary at the beginning of the study. They had cardiovascular risk factors and reported symptoms of MCI. […]
New research suggests that vital exhaustion, a marker of psychological distress, may raise the risk of developing Alzheimer’s disease. Psychological distress in midlife may bring about dementia later on, suggests new research. Many factors may increase Alzheimer’s risk, including age, family history, and genetic makeup. Certain health issues, such as cardiovascular disease or diabetes, may also influence the odds of experiencing dementia because they impact the blood vessels. New research indicates that psychological factors could also affect risk. Psychological distress, in particular, may increase the likelihood of developing dementia, suggests the new study. Specifically, researchers led by Sabrina Islamoska, a doctoral candidate in the Department of Public Health at the University of Copenhagen, Denmark, set out to investigate the possibility of a link between vital exhaustion and Alzheimer’s disease. Vital exhaustion describes “a mental state of psychological distress” that manifests as irritability, fatigue, and a feeling of demoralization. As the researchers explain, vital exhaustion may be a reaction to “unsolvable problems” in one’s life, especially when the person has been exposed to stressors for a prolonged period. So, vital exhaustion can be seen as a sign of psychological distress. Previous studies have noted that vital exhaustion may raise the risk […]
Recent research adds to a growing body of knowledge that links hearing loss with cognitive decline, which is a hallmark of dementia and often precedes the disease. Research suggests a link between hearing loss and cognitive decline. After analyzing 8 years of data from a health study of more than 10,000 men, scientists at Brigham and Women’s Hospital and Harvard Medical School, both in Boston, MA, found that hearing loss is tied to an appreciably higher risk of subjective cognitive decline. In addition, the analysis revealed that the size of the risk went up in line with the severity of hearing loss. The risk of subjective cognitive decline was 30 percent higher among men with mild hearing loss, compared with those with no hearing loss. For men with moderate or severe hearing loss, the risk of subjective cognitive decline was between 42 and 54 percent higher. Subjective cognitive decline refers to changes in memory and thinking that people notice in themselves. Such changes can be an early indication of cognitive decline that objective performance tests do not pick up on. “Our findings,” says lead study author Dr. Sharon Curhan, who works as a physician and epidemiologist, “show that hearing loss […]
Recent research into older adults confirms that loneliness is tied to a raised risk of developing dementia. The study also reveals that the effect ranges across a diversity of people and is independent of how much social contact they have. A large new study confirms that loneliness is a risk factor for dementia. Scientists from Florida State University (FSU) in Tallahassee used data on 12,030 individuals from the Health and Retirement Study, a United States government-sponsored longitudinal survey of a nationally representative sample of people aged 50 and older. They report their findings in a paper that now features in The Journals of Gerontology: Series B. “We are not the first people,” says first study author Dr. Angelina Sutin, who is an associate professor in FSU’s College of Medicine, “to show that loneliness is associated with increased risk of dementia.” “But this is by far the largest sample yet, with a long follow-up,” she adds. “And the population was more diverse.” The study data contained measures of loneliness and social isolation and a range of risk factors, including behavioral, clinical, and genetic. Through telephone interviews, individuals had also completed assessments of cognitive ability, a low score on which indicates dementia. […]
As we age, we may experience a decline in our mental ability. A recent study has concluded that chronic inflammation in midlife might speed up this decline as we get older. Could influencing inflammation slow cognitive decline? The average age of the population of the United States is gradually increasing, so conditions of old age are moving into the spotlight. Growing older is associated with a progressive decline in average thinking abilities. However, it may only affect some people very mildly, while other individuals can develop significant cognitive deficits. Understanding the risk factors involved is of growing importance. We already know some risk factors; for instance, lower levels of physical activity, smoking, and obesity appear to increase the rate of decline. Recently, some scientists have turned their attention toward the potential role of inflammation. Inflammation and its consequences As a protective mechanism that prevents any damage to tissue, inflammation occurs in response to an infection or injury. However, if this acute inflammation continues for longer periods — which doctors call chronic inflammation — it can cause damage. Scientists have already linked inflammation to a range of health concerns, including cardiovascular disease, cancer, diabetes, and asthma. Could inflammation also have a […]
By Alan MozesHealthDay Reporter Latest Alzheimer’s News THURSDAY, June 27, 2019 (HealthDay News) — Every college student misplaces keys or forgets an appointment from time to time. Usually it’s no big deal. But a new study warns that when young people with a family history of Alzheimer’s disease have memory lapses, it could be an early sign of something serious. That’s the concern raised by a new memory test taken by nearly 60,000 men and women between the ages of 18 and 85. The results revealed that participants between 18 and 65 who had family members with Alzheimer’s scored lower than those who did not. That included even young adults in their 20s. But, “no one should feel doomed to experience Alzheimer’s, certainly not simply because your parents or grandparents were diagnosed with the disease,” stressed study author Matt Huentelman. He is a professor of neurogenomics with TGen, a genetics research institute based in Phoenix. Lots of non-inherited factors play a role in Alzheimer’s risk, he explained. And, “there are many cases of people with family history and/or high genetic risk for Alzheimer’s who live long lives without memory problems.” But there’s no getting around the fact that roughly 75% […]
(HealthDay News) — It’s taking you longer than it once did to learn a new task. Or you’ve forgotten about today’s doctor’s appointment. Should you be worried? Latest Alzheimer’s News In other words, do you have mild forgetfulness or symptoms of a more serious memory problem? The National Institute on Aging says you should speak to your doctor, who can help determine if your memory and thinking problems are normal or not, and what might be causing them. Signs of a more serious memory issue include: Asking the same questions repeatedly. Getting lost in familiar places. Not being able to follow instructions. Becoming confused about time, people or places. Copyright © 2018 HealthDay. All rights reserved.
By Amy NortonHealthDay Reporter Latest Alzheimer’s News FRIDAY, June 21, 2019 (HealthDay News) — Researchers have found more evidence of a puzzling phenomenon: Older adults who survive cancer seem to be somewhat protected against dementia. A number of studies in recent years have found that cancer survivors have a relatively lower risk of developing Alzheimer’s. The new research adds another layer. It shows that even before their diagnosis, older adults who go on to develop cancer have an edge when it comes to memory performance. Among the older Americans who were tracked for 16 years, those who developed cancer typically had sharper memory skills — both before and after the diagnosis — than those who remained cancer-free. Researchers said it all supports the theory that some of the biological processes that contribute to cancer may actually protect against dementia. But the big remaining question is, what are those mechanisms? “We’re really interested in understanding what [they] could be, because it might point the way to strategies to prevent dementia,” said senior researcher Maria Glymour, a professor at the University of California, San Francisco School of Medicine. The study findings are based on more than 14,500 U.S. adults born before 1949. […]
Researchers are finding new evidence that exercise — even low-intensity, casual physical activity — can boost brain health in the short- and long-term. Frequent but leisurely exercise can boost brain health. Evidence that exercise can benefit the brain and help maintain cognitive function — including memory — is accumulating. One study, for instance, suggests that engaging even in low-level phyisical activities, such as doing household chores, can help reduce the risk of cognitive impairment in older adults. Now, a team led by Michelle Voss — from the University of Iowa in Iowa City — has found evidence in support of the notion that the benefits of just one workout can predict the benefits of frequent physical activity in the long run. The team presented these findings at this year’s Cognitive Neuroscience Society’s symposia in San Francisco, CA. As symposium chair Wendy Suzuki, of New York University in New York City, explains, “There is a strong and direct link between physical activity and how your brain works.” “People still do not link physical health to brain and cognitive health; they think about fitting into a bikini or losing that last pound, not about all the brain systems they are improving and […]
Type 2 diabetes is a chronic condition that affects the body’s insulin production and blood sugar levels. New research, however, suggests that the scope of this condition may be broader than previously thought, as scientists find a link between type 2 diabetes and cognitive decline over 5 years. New research suggests that type 2 diabetes may affect brain size in midlife. Michele Callisaya, from the University of Tasmania in Hobart, Australia, led the new research. Callisaya and her colleagues set out to investigate if there was an association between type 2 diabetes, on the one hand, and brain atrophy and cognitive decline, on the other. Moreover, in case the researchers found such a connection, they wanted to discover whether there was a causal relationship underlying it. The researchers recruited 705 people aged between 55 and 90 years from the so-called Cognition and Diabetes in Older Tasmanians study and took measures of the participants’ brains and cognition. To the authors’ knowledge, this is the first study to compare both cognition and brain size among people with and without type 2 diabetes. The results appear in Diabetologia, the journal of the European Association for the Study of Diabetes. Type 2 diabetes tied […]
What is memantine, and how does it work (mechanism of action)? Memantine is an oral medication for treating patients with Alzheimer’s disease. Other medications used for Alzheimer’s disease affect acetylcholine, one of the neurotransmitter chemicals that nerve cells in the brain use to communicate with one another. These drugs – galantamine (Razadyne – formerly known as Reminyl), donezepil (Aricept), rivastigmine (Exelon), and tacrine (Cognex) – inhibit the enzyme acetylcholinesterase that destroys acetylcholine and thereby increase the effects of acetylcholine. Memantine’s effects are independent of acetylcholine and acetylcholinesterase. Glutamate is the main excitatory neurotransmitter in the brain. It is believed that too much stimulation of nerve cells by glutamate may be responsible for the degeneration of nerves that occurs in some neurological diseases such as Alzheimer’s disease. Like other neurotransmitters, glutamate is produced and released by nerve cells in the brain. The released glutamate then travels to nearby nerve cells where it attaches to a receptor on the surface of the cells called the N-methyl-D-aspartate (NMDA) receptor. Memantine blocks this receptor and thereby decreases the effects of glutamate. It is thought that by blocking the NMDA receptor and the effects of glutamate, memantine may protect nerve cells from excess stimulation by […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Dec. 20, 2018 (HealthDay News) — Walking and other types of moderate exercise may help turn back the clock for older adults who are losing their mental sharpness, a new clinical trial finds. The study focused on older adults who had milder problems with memory and thinking skills. The researchers found that six months of moderate exercise — walking or pedaling a stationary bike — turned some of those issues around. Specifically, exercisers saw improvements in their executive function — the brain’s ability to pay attention, regulate behavior, get organized and achieve goals. And those who also made some healthy diet changes, including eating more fruits and vegetables, showed somewhat bigger gains. The effect was equivalent to shaving about nine years from their brain age, said lead researcher James Blumenthal, a professor at Duke University School of Medicine, in Durham, N.C. In contrast, those same mental abilities kept declining among study participants who received health education only. Experts said the findings support the general concept that a healthy lifestyle can help protect the brain as you age. “And it’s never too late to start,” said Keith Fargo, director of scientific programs and […]
Latest Alzheimer’s News SUNDAY, Nov. 25, 2018 (HealthDay News) — People caring for a loved one with Alzheimer’s or other types of dementia should focus on four main safety issues, an expert says. Nearly 6 million Americans have Alzheimer’s disease, according to the Alzheimer’s Association. About 16.1 million Americans provide unpaid care for people with Alzheimer’s or other dementias. “When approaching dementia families, I follow the safe and sane rule,” said Dr. Andrew Duxbury, a geriatrician in the Division of Gerontology, Geriatrics and Palliative Care at University of Alabama at Birmingham. “Everything we do needs to make the patient safe and the family sane. In terms of safety, it boils down into the big four: meals, wheels, bills and pills,” he explained in a university news release. In terms of meals, caregivers need to consider whether the person is capable of preparing food, eating healthy and appropriate amounts of food, and has the awareness that they need to eat, Duxbury said. “If any link in that chain breaks, the person may not eat,” he said. When it comes to kitchen safety, the “biggest issue is leaving things on the stove and forgetting to turn the oven off; but if cooking […]
Blocking an enzyme could put a stop to the buildup of toxic protein clumps that occurs in the brains of people with Parkinson’s disease. New research reveals that blocking a certain protein clears Lewy bodies — toxic structures that are a hallmark of Parkinson’s disease. This was the conclusion that scientists at Georgetown University Medical Center (GUMC) in Washington, D.C. reached after studying the enzyme, called USP13, in the brains of mice and humans. The study, which features in the journal Human Molecular Genetics, may be the first to explain USP13’s role in the toxic accumulation of protein clumps in the brain. The protein accumulations are called Lewy bodies, and they also occur in other neurodegenerative diseases, including Lewy body dementia and multiple system atrophy. “This study,” says lead author Xiaoguang Liu, an assistant professor of neurology at GUMC, “provides novel evidence that USP13 affects development and clearance of Lewy body protein clumps, suggesting that targeting USP13 may be a therapeutic target in Parkinson’s disease and other similar forms of neurodegeneration.” Parkinson’s disease and Lewy bodies Parkinson’s disease is a degenerative disorder that chiefly affects movement control. Typical symptoms include tremors, stiffness, and bradykinesia, which is a slowness of movement. […]
Researchers reveal a marker and new testing tool of frontotemporal dementia that may help distinguish this condition from Alzheimer’s disease. ‘Moral emotions’ are ones that prompt us to do good and contribute to pro-social behavior and cooperation. Frontotemporal dementia (FTD) is a less common form of dementia than Alzheimer’s. Sometimes called Pick’s disease or frontal lobe dementia, this condition occurs when brain cells in the frontal or temporal lobes of the brain, or both, become damaged. The frontal lobes of a person’s brain are responsible for problem-solving, planning, emotional control, and behavior. FTD may also affect the temporal lobes, which can be found on each side of the brain and deal with speech, the meaning of words, and recognition of faces or objects. In addition to difficulties with language, FTD also causes changes in personality and behavior. For instance, people with FTD may experience mood changes that do not normally characterize them. They may act more impulsively, lose their social inhibitions, feel apathetic, or lose interest in the emotions of other people or in socializing. Although some of these symptoms are similar to other, more common forms of dementia, such as Alzheimer’s disease, FTD is different from Alzheimer’s. In an […]
You have chosen to share the following article: How elderberries can help you fight the flu To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don’t include any URLs in your comments, as they will be removed upon submission. We do not store details you enter into this form. Please see our privacy policy for more information. Message sent successfully The details of this article have been emailed on your behalf. Click here to return to the Medical News Today home page.
Building on decades of research, a new paper brings us one step closer to a vaccine that targets the neurological hallmarks of Alzheimer’s disease. Prevention may soon be possible. Scientists inch closer to finding a way to prevent Alzheimer’s disease. Alzheimer’s disease, the most common form of dementia, is a degenerative neurological disease. Memory issues are often the first sign of the condition, which steadily progresses over time. Alzheimer’s disease is a growing concern as it appears almost exclusively in older adults. As the number of older people rises in the United States, the number of cases will also increase. Although scientists are still investigating the exact causes of Alzheimer’s disease, they believe that certain neurological markers play a significant role. The disease seems to involve a buildup of specific proteins in the brain called beta-amyloid and tau. Doctors refer to these abnormal congregations as plaques and neurofibrillary tangles respectively. The hunt for a vaccine Current treatments for Alzheimer’s do not stop disease progression, so the search for effective alternatives is ongoing. Some researchers hope that targeting amyloid buildup might make it possible to stop Alzheimer’s in its tracks. Many scientists are on the hunt for a vaccine, including Dr. […]
As interest in gut bacteria peaks, they are implicated in yet another condition. Researchers recently identified stark differences in levels of specific gut bacteria in people with dementia. A new study links changes in gut bacteria to dementia. Our bodies swarm with microscopic visitors. On our skin, in our mouths, deep in our lungs, and, of course, nestled in our digestive systems. The bacteria in the gut have long been known to assist the digestive process, but in recent years, it has become clear that they are involved in much, much more. With bacteria now implicated in conditions as diverse as diabetes and schizophrenia, we truly are in the age of the microbiome. Recently, researchers in Japan investigated whether gut bacteria might, one day, help in the diagnosis and even treatment of dementia. Dr. Naoki Saji, from the Center for Comprehensive Care and Research on Memory Disorders at the National Center for Geriatrics and Gerontology in Obu, Japan, led the team of scientists. The researchers will present their findings at the American Stroke Association’s International Stroke Conference 2019 in Honolulu, HI. Examining feces The researchers recruited 128 participants from their memory clinic. The average age was 74.2, and 59 percent […]
(HealthDay News) — If you are caring for a loved one who has Alzheimer’s disease, you may develop feelings of grief as the person starts to change, the Alzheimer’s Foundation says. Latest Alzheimer’s News There are five phases of grieving: denial, anger, guilt, sadness and acceptance. The association suggests how to cope with grief and loss: Face your feelings and accept them. Prepare to have feelings of loss as dementia progresses. Understand that no two people grieve in exactly the same way. Talk with someone you trust about your feelings. Stay involved in activities that you enjoy. Join a support group. Accept things that you cannot change. Take care of yourself. Copyright © 2018 HealthDay. All rights reserved. CONTINUE SCROLLING FOR NEXT NEWS ARTICLE
Could taking good care of gums and teeth also help to protect the brain? A recent study has added to growing evidence of a link between severe gum disease, or periodontitis, and a raised risk of dementia. New research suggests that keeping your gums healthy may prevent dementia. Using data from an extensive national health insurance screening program, investigators from Seoul National University in South Korea examined the relationship between chronic periodontitis and dementia. In a paper that now features in the Journal of the American Geriatrics Society, the researchers describe how they found a modest link between severe gum disease and dementia, which is consistent with some previous studies. The researchers also point out that their “retrospective cohort study” is likely the first to establish that lifestyle factors, such as alcohol consumption, smoking, and exercise, did not appear to have any effect on the connection. The term dementia describes a decline in mental capacity – such as increasing difficulty with memory and reasoning – that becomes so severe that it disrupts daily living. Alzheimer’s disease is the most common cause of dementia. Need to reduce dementia risk factors A joint 2012 report by the World Health Organization (WHO) and […]
Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — Rates of Alzheimer’s disease are higher in women than in men, and researchers now think they know why. A team from Vanderbilt University Medical Center, in Nashville, Tenn., has identified gender differences in how the Alzheimer’s-related protein tau spreads in the brain. Research suggests that tau spreads through the brain like an infection, moving from neuron to neuron and turning other proteins into abnormal tangles that result in the death of brain cells. In this study, investigators used data from positron emission tomography (PET) scans of healthy people and patients with mild mental (cognitive) impairment to create a graph analysis of how tau spreads. “It’s kind of like reconstructing a crime scene after a crime. You weren’t there when it happened, but you can determine where an intruder entered a house and what room they entered next,” said lead investigator Sepi Shokouhi, an assistant professor of psychiatry and behavioral sciences. “The graph analysis does something similar to show how tau spreads from one region to another,” Shokouhi explained in a center news release. The researchers found that the structure of tau networks is different in men and women, with women […]
Millions of people worldwide live with a form of dementia, the most common of which is Alzheimer’s disease. Currently, there is no way to halt its progress, but clinical trials of new drugs are underway. What approach will serve specialists best? A new review of clinical trials advises on the best way forward. According to the World Health Organization (WHO), approximately 50 million people around the world live with dementia, and approximately 60–70 percent have Alzheimer’s disease. The greatest risk factor for Alzheimer’s disease is aging, and people ages 65 or older are the most vulnerable. Current treatments for this condition address its symptoms, such as memory loss and behavioral changes. However, more and more research aims to find a therapy that will tackle the biological changes that characterize Alzheimer’s disease. But are researchers on the right track with their investigations, and what would be the best treatment approach? A new comprehensive review published in the journal Neurology, and available online, addresses these questions. Most trials target brain pathologies In the review, specialists from the Alzheimer’s Drug Discovery Foundation in New York, NY analyze current clinical trials for dementia drugs and advise about the best approach going forward. “Alzheimer’s is […]
New research shows that a blood test for Alzheimer’s disease accurately detected levels of beta-amyloid protein in all stages of the condition, approaching “a level of accuracy that is usable in routine clinical care around the world.” Doctors could soon use a simple blood test to diagnose Alzheimer’s. The brain changes that lead to the symptoms of Alzheimer’s disease can occur decades before any other signs of the condition are noticeable. In fact, some recent studies have claimed that certain biochemical changes in the brain may occur up to 34 years before symptom onset. Detecting Alzheimer’s disease far enough in advance could make it easier for those affected to plan accordingly and begin treatment as early as possible. Beginning treatment for Alzheimer’s disease as soon as possible can maximize the effectiveness of the therapy. So, to be able to diagnose the condition as early as possible, researchers have been trying to come up with blood tests for Alzheimer’s disease. For instance, last year, a team of scientists developed a test that detected the protein beta-amyloid from blood samples using immuno-infrared sensor technology. Having a lot of this protein in the brain is a hallmark of Alzheimer’s. At the time, the […]
Latest Alzheimer’s News MONDAY, Nov. 26, 2018 (HealthDay News) — An experimental Alzheimer’s disease vaccine shows promise in animal tests, and researchers say it could have the potential to reduce dementia cases by half. In mice created to develop Alzheimer’s, the vaccine triggered an immune response that reduced accumulation of two toxic proteins associated with the fatal brain disease. There was a 40 percent reduction in beta-amyloid proteins and up to a 50 percent reduction in tau proteins, with no harmful side effects, according to researchers at the University of Texas. But there’s a catch: While such tests showed positive results in mice, research on animals doesn’t always produce the same effects in humans. More study is needed. Still, the researchers remained optimistic. Reductions in these proteins could someday have significant benefits in people at risk for Alzheimer’s disease, said study senior author Doris Lambracht-Washington, of the UT Southwestern Medical Center Brain Institute in Dallas. “If the onset of the disease could be delayed by even five years, that would be enormous for the patients and their families,” she said in a center news release. “The number of dementia cases could drop by half.” Lead researcher Dr. Roger Rosenberg is […]
The majority of people with sleep apnea do not receive a diagnosis. However, brain scans have revealed that there may be an association between this condition and a form of dementia. There may be an association between sleep apnea and dementia, according to a recent study. According to the American Sleep Apnea Association (ASAA), an estimated 22 million people in the United States have sleep apnea. This condition, which causes a person to stop breathing during sleep, can be infrequent or regular. Doctors refer to regular sleep apnea as obstructive sleep apnea. Without treatment, it can lead to a number of cardiovascular problems, including high blood pressure, stroke, and chronic heart failure. Obstructive sleep apnea also has links to both depression and type 2 diabetes. “Recent research has linked sleep apnea to an increased risk of dementia,” notes Dr. Diego Z. Carvalho, a neurology fellow at the Mayo Clinic in Rochester, MN. Along with colleagues, he authored a study to investigate whether there was a potential relationship between sleep apnea and a particular Alzheimer’s biomarker. This biomarker is a protein called tau, which is present in the brains of people with Alzheimer’s. Tau proteins form tangles that doctors can identify […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Feb. 28, 2019 (HealthDay News) — The old saying, “TV rots your brain,” could have some validity for folks as they age. In a new study, middle-aged people who watched television for more than 3.5 hours a day experienced a decline in their ability to remember words and language over the next six years, British researchers found. What’s worse, it appears that the more TV you watch, the more your verbal memory will deteriorate, researchers said. “Overall, our results suggests that adults over the age of 50 should try and ensure television viewing is balanced with other contrasting activities,” said lead researcher Daisy Fancourt. She’s a senior research fellow at University College London. For the study, researchers relied on data from a long-term study of aging involving more than 3,600 residents of England. Participants reported the amount of hours of TV they watched daily. They also had their thinking and reasoning skills regularly tested as part of the study. People who watched less than 3.5 hours of TV a day didn’t seem to suffer any deterioration in their brain power, Fancourt said. But more than that amount, people became increasingly apt to […]
Recent research suggests that doing even low-intensity physical activity allows older people to reduce their risk of dementia. Carrying out even basic activities in older age might help maintain brain health. Several factors can affect a person’s chance of developing dementia. Some of the factors, such as age and genetics, are unavoidable. Others, such as smoking and other unhealthful behaviors, are lifestyle choices that a person can change. Regularly exercising and eating a healthful diet may prevent the onset of symptoms, say the Alzheimer’s Association. However, a new study that appears in the journal Neurology has revealed that any kind of physical activity — including basic tasks such as doing housework — may protect a person’s brain when they have already reached old age. The researchers — from Rush University Medical Center in Chicago, IL — studied 454 older adults. Of these, 191 had a diagnosis of dementia. Every participant agreed to donate their brain for medical research purposes when they died. Every year for 2 decades, each person underwent a full physical examination, along with a test, to determine their thinking and memory skills. The scientists gave all the volunteers an activity-monitoring device called an accelerometer around 2 years […]
A novel genetic approach that repairs broken connections between brain cells could lead to treatments that restore memory capacity in Alzheimer’s disease. By using epigenetics, it may soon be possible to reverse memory loss in Alzheimer’s disease. The new approach reverses changes to gene expression that tend to occur in the later stages of the disease. Scientists at State University of New York at Buffalo demonstrated how the method was able to reverse Alzheimer’s memory decline in mice. Much genetic research on the causes of Alzheimer’s disease focuses on changes in the DNA of genes. The new study, however, focuses on epigenetics, which concerns mechanisms that can switch genes on and off without disturbing their DNA code. A paper about the work now features in the journal Brain. “In this paper,” says senior study author Zhen Yan, Ph.D., who is a professor in the Department of Physiology and Biophysics, “we have not only identified the epigenetic factors that contribute to the memory loss, we also found ways to temporarily reverse them in an animal model of [Alzheimer’s disease].” Alzheimer’s disease and loss of synapses Alzheimer’s disease is the leading cause of dementia. According to the World Health Organization (WHO), between […]
The herpes virus could account for at least half of Alzheimer’s cases, according to a new review of the findings of three recent studies examining links between Alzheimer’s and herpes. Infection with the herpes simplex virus may boost the likelihood of developing Alzheimer’s, researchers suggest. The new paper, published in the Frontiers in Ageing Neuroscience journal, also suggests that antiviral drugs may reduce the risk of senile dementia — which is mostly caused by Alzheimer’s disease — among people who have severe cases of herpes. Herpes simplex virus 1 (HSV1) is the type of herpes that results in cold sores. HSV1 is a common virus, and the majority of people will have contracted it by the time they reach old age. However, the virus remains permanently in the body and cannot be decisively removed either by the body’s natural defense mechanisms or by drugs. The virus is inactive most of the time, but when a person has HSV1, they may find that flare-ups occur when they are stressed or sick, resulting in characteristic blisters. Medical News Today have reported on several studies this year alone that have provided evidence of a connection between Alzheimer’s and herpes. In June, we looked […]
Dementia refers to a series of neurodegenerative diseases, such as Alzheimer’s, where a person’s memory and other cognitive abilities decline. A recent study may have found a new risk factor that might predispose people to dementia: lung disease. To limit the risk of dementia, people may also want to look after the health of their lungs, a new study suggests. According to the study by researchers from the University of Minnesota’s School of Public Health in Minneapolis in collaboration with colleagues from other academic institutions in the United States, people who experience lung disease in midlife may have an increased risk of dementia later on. The study’s findings appear in the American Journal of Respiratory and Critical Care Medicine, a journal of the American Thoracic Society. The research indicates associations between both restrictive and obstructive lung diseases and dementia or cognitive impairment risk. Doctors use the term restrictive lung diseases when the lungs are unable to expand. Such diseases include idiopathic pulmonary fibrosis, in which the lungs present scarring, and sarcoidosis, where some lung tissue becomes abnormally swollen. In obstructive lung diseases, something obstructs the air flow in or out of the lungs. The most common type of obstructive lung […]
There is no doubt that smoking damages health and increases the risk of many diseases and premature death. However, a study that followed hundreds of older adults for more than 10 years found no link between tobacco smoking and raised dementia risk. A new study suggests there is no causal link between smoking and the risk of developing dementia. Dementia is the general name for conditions that diminish the capacity to think, remember, reason, and interact with others. These symptoms can progress to the point that people are no longer able to carry out their daily activities and take care of themselves. The recent finding contradicts many earlier studies that have tied smoking to higher risk of dementia. This could be because, for the new investigation, researchers from the University of Kentucky in Lexington analyzed the data in a different way. They used a statistical method called “competing risk analysis” to allow for the strong effect that smoking has on risk of death. In a paper that now features in the Journal of Alzheimer’s Disease, first study author Erin L. Abner Ph.D., an associate professor in the university’s Sanders-Brown Center on Aging, and her colleagues describe their approach and findings. […]
Experts have already concluded that exercise can help people with Parkinson’s disease improve their motor symptoms, but what is its effect on the cognitive symptoms of this condition? Besides boosting motor function, exercise could improve memory in people with Parkinson’s disease. Parkinson’s disease is a neurological condition that usually stands out for the motor symptoms that it causes, which include tremors, rigidity in the limbs, impaired balance, and a lack of control over movements. However, this condition also has numerous other symptoms that can leave their mark on a person’s quality of life. Cognitive symptoms, in particular, have been worrying researchers interested in the pathology of Parkinson’s disease. People with this condition experience cognitive impairment, which can worsen in time and eventually evolve into Alzheimer’s disease. When it comes to managing Parkinson’s, doctors often advise their patients to take up an exercise regime, since physical activity demonstrably helps improve motor symptoms. The Parkinson’s Foundation call exercise routines “a vital component” of efforts to maintain the quality of life following diagnosis. But how does physical activity affect other symptoms of Parkinson’s disease, particularly cognitive ones? This is the question that a team of researchers from the German Sport University, in Cologne, […]
A blood test can identify the protein that builds up in the brains of people with Alzheimer’s nearly 20 years before symptoms appear, a new study shows. A simple blood test could soon predict symptoms of Alzheimer’s disease decades before they appear. The study found that the blood test was even more sensitive at detecting the buildup of beta-amyloid proteins in the brain than the current gold standard, which is a PET brain scan. Researchers from Washington University School of Medicine (WUSTL) in St. Louis, MO, conducted the study, which appears in the journal Neurology. First author Dr. Suzanne Schindler, an assistant professor of neurology, led the researchers, who first developed a version of this test a couple of years ago. The test uses mass spectrometry on blood samples to detect the presence of two forms of the beta-amyloid protein: beta-amyloid 42 and beta-amyloid 40. When beta-amyloid deposits in the brain start to build up, the ratio between the two forms of the protein goes down. The blood test can detect this change. The study involved 158 adults who were at least 50 years old, and all but 10 had normal cognitive function. For the study, each person had a […]
For years, many experts have assumed that spending more time in education protects against dementia. The latest study may overturn this long-held theory. A new study examines the links between education and dementia risk over time. It will have escaped no one’s attention that dementia is on the rise. The most common type of dementia is Alzheimer’s. According to the Alzheimer’s Association, an estimated 5.7 million adults in the United States have Alzheimer’s. Primarily due to our increasing lifespan, dementia incidence is set to keep rising. Currently, there is no cure, and treatments can only reduce certain symptoms. For this reason, it is vital that we understand the relevant risk factors and discover ways to prevent or slow down dementia. Some risk factors are well-known, such as smoking and lack of physical activity. Well-known protective factors include sticking to a healthful diet. Education and cognitive reserve Many experts think that the length of time someone spends in education helps protect against dementia. Although studies have generated conflicting or inconclusive results, many researchers believe that higher levels of educational attainment provide an individual with a certain “cognitive reserve.” Scientists believe that this hypothetical reserve lowers the risk or, at the very […]
Doctors may find it hard to diagnose Alzheimer’s disease before the obvious symptoms set in, and many of the current tests for it are expensive and complicated. However, researchers recently devised a blood test that could accurately detect this condition. Recent research aimed to develop an accurate blood test to diagnose Alzheimer’s. According to the Alzheimer’s Association, the condition will affect an estimated 5.7 million people in the United States by 2050. Despite this, there are few ways of accurately diagnosing Alzheimer’s disease early on. These include MRI and CT scans, which help doctors rule out other conditions that might cause similar symptoms. Another way of diagnosing Alzheimer’s is by collecting cerebrospinal fluid and looking for biomarkers of the disease. This is the most accurate test for this neurodegenerative condition, but it is costly and invasive. For all these reasons, researchers from Brigham and Women’s Hospital in Boston, MA, have been developing a blood test for Alzheimer’s that aims to be accurate, more cost-effective, and less unpleasant. In the study paper, which appears in the journal Alzheimer’s & Dementia, the researchers explain that the test may be able to detect biomarkers of Alzheimer’s disease before the appearance of obvious symptoms. […]
It is still unclear exactly what causes Alzheimer’s disease, which is a neurodegenerative condition chiefly characterized by memory loss and other forms of cognitive impairment. However, new research is uncovering more of the factors that contribute to its pathology. According to a new study, a blood protein leaked into the brain contributes to cognitive decline. According to existing guidelines, the main mechanism associated with cognitive problems in the brains of people with Alzheimer’s disease is the formation of beta-amyloid plaques. These are buildups of toxic proteins that disrupt the normal functioning of synapses. Synapses are the connections formed between brain cells that allow information to circulate within and to and from the brain. However, in a new study from the Gladstone Institutes in San Francisco, CA, a team of researchers has identified another mechanism that affects how synapses work, contributing to Alzheimer’s pathology. The researchers began by investigating problems that appear in the blood vessel network in the brain, which is another biological characteristic of this form of dementia. Senior investigator Prof. Katerina Akassoglou and her team have for the first time identified a blood-derived protein that leaks into the brain disrupting cell-to-cell communication. The findings, which appear in the […]
Ketogenic, or keto, diets are low-carb and fat-rich, and many people who follow such regimens do it to shed excess weight. However, a keto diet may bring other benefits, too. In particular, it may help keep the brain healthy and young, as new research in mice seems to suggest. Can a keto diet protect brain health, and if so, how? A keto diet is high in fat, low in carbohydrates, and has an adequate amount of protein. This kind of diet is meant to trigger ketosis, which is a metabolic process through which the body breaks down fat and protein and transforms them into energy, leading to weight loss. Besides triggering weight loss, a keto diet may also bring other health benefits, as studies have recently suggested. For instance, one such study argued that keto diets could help reduce the side effects of certain cancer therapies. Now, researchers from the Sanders-Brown Center on Aging at the University of Kentucky in Lexington, KY, are assessing evidence suggesting that keto diets may also help stave off cognitive decline. The scientists conducted two studies, both in mice. The findings indicate that keto-type diets can protect neurovascular function, as well as metabolic function, in […]
Mushrooms are a much-loved ingredient in cuisines around the world. They are nutritious and especially rich in antioxidants, which protect cell health. Researchers are now asking whether mushrooms can also protect against cognitive decline. Eating mushrooms may help keep cognitive decline at bay. Mushrooms are fascinating. Although some are edible and grocery stores sell them in their “vegetable” aisles, they aren’t actually vegetables. They are actually fungi, a kingdom all of its own, alongside those of plants and animals in biological classifications. Edible mushrooms — both cultivated and wild species — contain a high amount of dietary fiber, antioxidants, and protein, as well as vitamins and minerals. New research has found that people who integrate mushrooms into their diets — even if they only consume them in small portions — appear to have a lower risk of mild cognitive impairment (MCI), which often precedes Alzheimer’s disease. In MCI, a person may experience some symptoms characteristic of Alzheimer’s disease — such as poor memory and issues with language and spatial orientation — but in a much subtler way that does not prevent them from continuing to lead a fully functional life. Researchers at the National University of Singapore (NUS) near Clementi […]
A recent article raises important questions about the prevalence of firearms in the aging population of the United States. The authors argue that there is a vital need to discuss the relationship between dementia and guns. A recent article investigates the issue of gun ownership in an aging population. Gun ownership is a controversial topic, and people are sure to continue debating it for many years to come. This debate often focuses on young men and violent crime, but a recent article investigates the other end of the age spectrum. Older adults are more likely to own a gun than younger people. An estimated 27 percent of people over the age of 65 years own at least one gun, while 37 percent live in a home where a firearm is present. A seemingly unrelated but equally hot topic is the rise of dementia. Dementia and firearms As dementia occurs almost exclusively later in life, the longer that people live, the more prevalent it becomes. Currently, around 5.7 million people in the U.S. are living with Alzheimer’s disease. Although Alzheimer’s is the most common form of dementia, it only accounts for 60–80 percent of all dementia cases. A recent article in […]
Latest Alzheimer’s News FRIDAY, Jan. 18, 2019 (HealthDay News) — Frailty is associated with a higher risk of both Alzheimer’s disease and its crippling symptoms, a new study shows. “By reducing an individual’s physiological reserve, frailty could trigger the clinical expression of dementia when it might remain asymptomatic in someone who is not frail,” said study leader Dr. Kenneth Rockwood, a professor at Dalhousie University in Halifax, Canada. “This indicates that a ‘frail brain’ might be more susceptible to neurological problems like dementia as it is less able to cope with the pathological burden,” he added. The study included 456 adults in Illinois, aged 59 and older, who did not have Alzheimer’s when first enrolled in the Rush Memory and Aging Project. They underwent annual assessments of their mental and physical health, and their brains were examined after they died. By their last assessment, 53 percent of the participants had been diagnosed with possible or probable Alzheimer’s disease. For the physical assessments, the researchers created a frailty index using 41 components, including fatigue, joint and heart problems, osteoporosis, mobility and meal preparation abilities. Overall, 8 percent of the participants had significant Alzheimer’s disease-related brain changes without having been diagnosed with […]
Researchers are growing increasingly interested in the relationship between blood pressure and dementia. The most recent study investigates how patterns of change in blood pressure over the decades might influence risk. What can blood pressure fluctuations tell us about dementia risk? As the United States population ages, dementia incidence rises in tandem. Today, around 5 million people in the U.S. have a dementia diagnosis. Studies published over the last few years have produced evidence that hypertension (high blood pressure) during midlife appears to increase the risk of dementia and cognitive decline. Hypertension affects an estimated 1 in 3 adults in the U.S., so it is vital to understandi the exact relationship between blood pressure and the aging brain. Researchers have done less work to investigate the links between blood pressure during later life and cognitive outcomes. However, as the authors of a recent study explain, the findings hint that “optimal blood pressure ranges for older adults may depend on earlier blood pressure characteristics.” In other words, the impact of hypertension on the aging brain may depend on the pattern of blood pressure from midlife onward. Blood pressure changes through life The authors of the current study, published in JAMA Network, […]
Latest Alzheimer’s News WEDNESDAY, March 27, 2019 (HealthDay News) — A dementia study has led researchers to a brain region that processes spoken, not written, words. Northwestern University researchers worked with four patients who had a rare type of dementia called primary progressive aphasia (PPA), which destroys language. Although able to hear and speak, they could not understand what was said out loud. However, they could still process written words. For example, if they read the word “hippopotamus,” they could identify a picture of a hippo. But if someone said the word “hippopotamus,” they couldn’t point to its picture. Through their tests with these patients, the researchers were able to identify an area in the left brain that appears specialized to process spoken words. “We always think of these degenerative diseases as causing widespread impairment, but in early stages, we’re learning that neurodegenerative disease can be selective with which areas of the brain it attacks,” said senior author Sandra Weintraub. She’s a professor of psychiatry and behavioral sciences and neurology at Northwestern’s Feinberg School of Medicine in Chicago. “The fact that only the auditory words were impaired in these patients and their visual words were untouched leads us to believe […]
The buildup of defective tau proteins is a prominent feature of neurodegenerative diseases such as Alzheimer’s. The faulty proteins form tangles that disrupt brain function and kill nerve cells, or neurons. Experiments in human cell cultures reveal a mechanism through which scientists can regulate defective tau protein levels. Now, scientists have identified a molecule that plays a vital role in helping to prevent the buildup of toxic tau protein in the brain. The molecule, which has the name vacuolar protein sorting 35 (VPS35), identifies and removes faulty tau proteins from neurons. Using human cells, researchers from Lewis Katz School of Medicine (LKSOM) at Temple University in Philadelphia, PA, showed that they could control tau buildup by altering levels of VPS35. They describe the findings in a Molecular Psychiatry study paper. “A major part of what VPS35 does,” says senior study author Prof. Domenico Praticò, director of LKSOM’s Alzheimer’s Center at Temple, “is to sort out and transport dysfunctional proteins to degradation sites.” The researcher and his colleagues also found that VPS35’s effect on tau depends on the activity of cathepsin D, an enzyme that breaks down proteins in cells. Neurons vulnerable to defective proteins The correct folding of proteins is […]
A drug that scientists are currently developing to treat stroke survivors might also help stave off Alzheimer’s disease. Researchers are trialing a new treatment that may help people with early-stage Alzheimer’s disease. Alzheimer’s disease is the most common form of dementia. According to the Alzheimer’s Association, 5.7 million people in the United States are living with the condition. Current medications can only relieve some symptoms of the disease, and there is not yet any way to halt its progression. The neurodegeneration that occurs in people with Alzheimer’s results from the buildup of a protein called beta-amyloid in the brain. Beta-amyloid is present in the healthy brain, but incorrectly folded proteins can accumulate to form amyloid plaques. These plaques reduce blood flow to the brain, leading to the breakdown of brain cells. Over the years, researchers have investigated many pharmacological routes to tackle these plaques, but, to date, none have led to the development of effective drugs. Recently, researchers from the University of Southern California (USC) in Los Angeles explored an innovative new compound that the scientific community is already scrutinizing. Introducing 3K3A-APC 3K3A-APC is a modified version of activated C protein, which is a blood-based protein that protects brain cells […]
New research finds that an HIV enzyme plays a crucial role in driving Alzheimer’s-related brain pathology by altering the APP gene. The findings warrant “immediate clinical evaluation of HIV antiretroviral therapies in people with Alzheimer’s disease,” say the authors of the study. The revelations of a recent study suggest that HIV drugs might successfully treat Alzheimer’s disease. Deemed “the most under-recognized public health crisis of the 21st century,” Alzheimer’s disease is the 6th leading cause of death in the United States and has no known cure. Currently, 5.7 million people ln the U.S. are living with the condition, and the Centers for Disease Control and Prevention (CDC) predict that the burden of the disease will double by 2060. Alzheimer’s also puts a significant strain on the American healthcare system. According to recent estimates, Alzheimer’s and other forms of dementia cost the U.S. $226 billion in 2015, and loved ones spend billions of unpaid hours caring for people with the condition. About 40 percent of these caregivers develop depression. The medical community is hard at work trying to understand how this debilitating disorder occurs and what can be done to stop it. For instance, one of the clues that researchers have […]
Following their study in rats, scientists have broken new ground in memory research. The finding concerns how the brain retrieves long-term memory and should open new avenues for investigating and treating Alzheimer’s disease and other causes of dementia. New research in rats has unveiled a brain mechanism that could explain how we retrieve old memories. Researchers at the University of Nevada, Las Vegas have discovered that two brain areas that work together to consolidate memories interact differently during the retrieval of remote memories. The two brain areas are the hippocampus and the anterior cingulate cortex (ACC). During consolidation, memory dependence transfers from the hippocampus to the ACC. However, the recent study reveals that during remote memory recall, the ACC takes the lead and drives the hippocampus. Graduate student Ryan A. Wirt and psychology professor James M. Hyman describe the 4 years of laboratory and analysis work that led to the findings in a Cell Reports paper. “Our research,” says Prof. Hyman, “opens up potential new avenues to explore why certain dementias and disorders lead to problems recalling long-term memories, which could help pave the way for future treatments that might be able to restore this ability to afflicted individuals.” Memory […]
An artificial intelligence tool taught to analyze brain scans can accurately predict Alzheimer’s disease several years before a final diagnosis. Researchers used PET scans to train a deep learning algorithm to predict signs of Alzheimer’s. The team responsible suggests that, after further validation, the tool could greatly assist the early detection of Alzheimer’s, giving treatments time to slow the disease more effectively. The researchers, from the University of California in San Francisco, used positron-emission tomography (PET) images of 1,002 people’s brains to train the deep learning algorithm. They used 90 percent of the images to teach the algorithm how to spot features of Alzheimer’s disease and the remaining 10 percent to verify its performance. They then tested the algorithm on PET images of the brains of another 40 people. From these, the algorithm accurately predicted which individuals would receive a final diagnosis of Alzheimer’s. On average, the diagnosis came more than 6 years after the scans. In a paper on the findings, which the Radiology journal has recently published, the team describes how the algorithm “achieved 82 percent specificity at 100 percent sensitivity, an average of 75.8 months prior to the final diagnosis.” “We were very pleased,” says co-author Dr. […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — One of the hallmarks of Alzheimer’s is the accumulation of beta-amyloid plaques in the brain, but what part those plaques play in the development of the disease isn’t clear. Now researchers have taken the first steps to trace the progression of plaque buildup in living patients. This way of “staging” the disease has implications for research and one day may help doctors treat this debilitating, fatal disease. “It is possible to stage individuals in terms of how advanced their beta-amyloid deposition is, using PET scans,” said lead researcher Dr. Niklas Mattsson, an associate professor of clinical neuroscience at Lund University in Sweden. When beta-amyloid appears, it follows certain stages, he explained. Some brain regions are involved early, others at the intermediate stage, and some in the late stage of Alzheimer’s. “These stages are also associated with other hallmarks of Alzheimer’s disease, such as levels of tau [another type of protein] in cerebral spinal fluid, cognitive decline and the wasting away of brain cells,” Mattsson added. “This staging system can be used both to improve research and perhaps also in clinical trials, to see if certain drugs […]
What brand names are available for ginkgo (Ginkgo biloba)-oral? Fossil Tree, Kew Tree, Silver Apricot Is ginkgo (Ginkgo biloba)-oral available as a generic drug? GENERIC AVAILABLE: Yes Do I need a prescription for ginkgo (Ginkgo biloba)-oral? No What are the uses for ginkgo (Ginkgo biloba)-oral? Ginkgo biloba is used for memory improvement, dementia, Alzheimer’s disease, anxiety, multiple sclerosis, tinnitus (ringing in the ears), sexual dysfunction, premenstrual syndrome, dizziness, headache, glaucoma, diabetic eye problems, and vertigo. What are the side effects of ginkgo (Ginkgo biloba)-oral? Side effects of gingko biloba are Possible serious side effects of gingko biloba include: bleeding in the eye or brain, severe bleeding after surgery, severe allergic reactions, difficulty breathing, seizures (eating fresh gingko seeds), and death (eating fresh gingko seeds). What is the dosage for ginkgo (Ginkgo biloba)-oral? Dosing may vary with the preparation (capsules, gels, extracts). Read manufacturer’s directions before using this product. Dementia: Take 120 – 240 mg per day in divided doses, 2 to 3 times a day. Vertigo and tinnitusTake 120 – 160 mg per day in divided doses, 2 to 3 times a day. Sexual dysfunctionTake 60 – 240 mg by mouth twice a day. Premenstrual symptoms Take 80 mg by […]
Latest Alzheimer’s News WEDNESDAY, May 1, 2019 (HealthDay News) — With findings that might alter the path of Alzheimer’s research, scientists say misfolded forms of two proteins appear to spread through patients’ brains similar to an infection. The findings suggest that Alzheimer’s is a “double-prion” disorder. This discovery could help lead to new treatments that focus directly on prions, according to researchers from the University of California, San Francisco. A prion is a misshapen protein that can force other copies of that protein into the same misfolded shape and spread in the brain. It’s best known for its role in bovine spongiform encephalopathy — “mad cow” disease — and Creutzfeldt-Jakob disease (CJD), a degenerative brain disorder. In the new research, the university team analyzed the brains of 75 Alzheimer’s patients after death and found self-propagating prion forms of the proteins amyloid beta and tau. Higher amounts of these prions were associated with early-onset Alzheimer’s and younger age at death. Alzheimer’s patients have amyloid plaques and tau tangles in the brain, but efforts to treat the disease by clearing out these inactive proteins have failed. These new findings suggest that active amyloid beta and tau prions could drive Alzheimer’s and offer […]
A new drug for treating Alzheimer’s disease has successfully passed the first phase of testing in humans. Preclinical studies had already shown that the drug could improve memory and other symptoms of Alzheimer’s disease in older mice. A potential treatment for Alzheimer’s moves a step closer. Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf, both in Germany, developed the candidate drug, which, for now, bears the name PRI-002. PRI-002 eliminates toxic beta-amyloid oligomers, the self-replicating proteins that scientists suspect of causing and advancing Alzheimer’s disease. The team had previously shown that the drug could significantly reduce signs and symptoms in older mice that were genetically engineered to develop an Alzheimer’s-like disease through the insertion of a mutant human gene. That preclinical study featured online in 2018 in the journal Molecular Neurobiology. In the ensuing, recently completed phase 1 clinical trial, healthy volunteers took daily dosages of PRI-002 for 4 weeks. The results show that the drug is safe for human use. Passing this stage of testing in humans means that the candidate drug can now proceed to a phase 2 trial to evaluate its effectiveness in people with Alzheimer’s disease. “Our next goal is the proof of efficacy in […]
A recent study has concluded that people with both higher-than-normal and lower-than-normal levels of hemoglobin have a higher risk of developing dementia as they age. A new paper looks at the link between hemoglobin and dementia risk. Hemoglobin is a protein present in red blood cells. It is responsible for carrying life giving oxygen from the lungs to the rest of the body. Low levels of hemoglobin normally signify anemia. Anemia is one of the most common blood disorders; worldwide, it affects an estimated 1.62 billion people. Low hemoglobin levels are linked to a number of adverse health outcomes, including stroke and coronary heart disease. However, there is little information regarding how hemoglobin levels might relate to the risk of dementia. Anemia and dementia Recently, researchers from the Erasmus Medical Center in Rotterdam, the Netherlands, decided to look for links between hemoglobin levels, anemia, and dementia. They published their findings this week in the journal Neurology. Earlier experiments had found an association between anemia and dementia, but most studies only followed participants for an average of 3 years. Because of the relatively short duration of these investigations, subtle changes in behavior, diet, or metabolism during the early phases of dementia […]
(HealthDay News) — If a loved one has symptoms of Alzheimer’s disease, he or she should visit a doctor for a formal evaluation. Latest Alzheimer’s News It may be easier to control the disease if it’s diagnosed early, the Alzheimer’s Association says. Here is the association’s list of other potential benefits of early diagnosis: Better access to treatment options. Possible participation in a clinical trial. More time to improve health concerns, such as obesity and high blood pressure. More time to spend with family and planning for the future. Copyright © 2019 HealthDay. All rights reserved.
The largest genetic study of Alzheimer’s disease to date finds that a “handful of gene variants” increases some people’s risk of both dementia and cardiovascular disease. The findings imply that, in principle, we may be able to repurpose some cardiovascular drugs to prevent or treat Alzheimer’s. The findings of a new study raise the question: could drugs for cardiovascular problems prevent Alzheimer’s? Alzheimer’s disease already affects a large number of older adults in the United States and worldwide, but the Centers for Disease Control and Prevention (CDC) warn that the burden of the condition will double in the U.S. by 2060. Currently, about 5.7 million Americans are living with the condition, and experts expect this number to reach almost 14 million in the next four decades. As a result, both tracking down the root cause of Alzheimer’s and moving closer to a cure are of critical importance. Researchers know that this neurodegenerative condition has a strong genetic component. For instance, a person with one copy of the APOE4 gene variant is twice as likely to develop Alzheimer’s as someone without it, while having two copies may increase the risk up to 12-fold. The APOE gene encodes a protein called apolipoprotein […]
New research suggests that “Life’s Simple 7” steps for maintaining heart health may also be a useful tool for predicting dementia risk and preventing the neurological condition. Managing your blood pressure is one of the seven actionable steps people in their 50s can take to maintain their cardiovascular health. The lead author of the new study is Séverine Sabia, of the department of Epidemiology of Ageing and Neurodegenerative Diseases at Inserm, a public research institution affiliated with the Université de Paris in France. Sabia and her colleagues set out to examine the link between the American Heart Association’s (AHA) guidelines for optimal cardiovascular health — which they dub “Life’s Simple 7” — and the risk of developing dementia later in life. “Life’s Simple 7” are modifiable risk factors which, according to the AHA, can help keep heart disease at bay. Making lifestyle changes along these seven parameters can improve a person’s cardiovascular health, the AHA advises. Life’s Simple 7 are: manage blood pressure manage cholesterol lower blood sugar stay physically active follow a healthful diet lose weight stop smoking (or don’t start) In the new research, Sabia and her team looked at how well people adhered to these steps at […]
By E.J. MundellHealthDay Reporter Latest Alzheimer’s News MONDAY, July 15, 2019 (HealthDay News) — Even if you are unlucky enough to carry genes that predispose you to Alzheimer’s disease, a healthy lifestyle can minimize that risk, new research shows. The study tracked the genetics, lifestyles and Alzheimer’s disease incidence of nearly 200,000 British people over 60 for an average of eight years. Researchers found that people who had a high genetic risk for Alzheimer’s and who followed unhealthy lifestyles had nearly triple the odds of getting the disease, compared to people with low genetic risk and a healthy lifestyle. Conversely, living well — exercising regularly, eating a balanced diet, not smoking, and drinking moderately — appeared to cut the odds for Alzheimer’s, even among those at high genetic risk. Among people found to be at highest genetic risk, healthy living appeared to reduce the chances of developing the disease by 35%, said a team led by David Llewellyn at the University of Exeter Medical School in England. That implies that “1 case of dementia would be prevented for each 121 individuals per [every] 10 years with high genetic risk who improved their lifestyle from unfavorable to favorable,” the researchers reported […]
In a new study, researchers have found that a bacterium largely responsible for gum disease also contributes to the development of Alzheimer’s disease. A bacterium involved in gum disease boosts Alzheimer’s toxicity. According to data from the National Institute of Dental and Craniofacial Research, 8.52 percent of adults between 20 and 64 years of age in the United States have periodontitis (gum disease). Gum disease is a widespread problem that can lead to more negative outcomes, from tooth loss to an increased risk of cancer. Now, emerging evidence suggests that one of the bacteria involved in periodontitis could also contribute to the accumulation of toxic proteins in the brain, which scientists have associated with the development of Alzheimer’s disease. These findings have emerged from a new study in mice that researchers from Cortexyme, Inc., a pharmaceutical company that aims to develop new therapeutics for Alzheimer’s disease, have conducted. The results of the research — whose lead author is Dr. Stephen Dominy, Cortexyme co-founder — appear in the journal Science Advances. “Infectious agents have been implicated in the development and progression of Alzheimer’s disease before, but the evidence of causation hasn’t been convincing,” notes Dr. Dominy. The bacterium that boosts brain […]
Latest Alzheimer’s News FRIDAY, June 7, 2019 (HealthDay News) — People with Alzheimer’s disease who take opioid painkillers are more likely to develop pneumonia, Finnish researchers report. The overall odds are 30% higher, especially in the first two months of use, the researchers found. And the risk is highest for those taking strong opioids such as oxycodone or fentanyl. However, pneumonia risk also rose among Alzheimer’s patients who took milder opioids, according to the team from the University of Eastern Finland. Why might this be? Aleksi Hamina, a researcher in the university’s School of Pharmacy, and colleagues explained that opioids can impair the cough reflex, interfere with normal respiratory function, and cause sleepiness and fatigue. All of these factors could increase pneumonia risk, the study authors said. For their study, the investigators analyzed data collected in 2010 and 2011 from more than 5,600 Alzheimer’s patients in Finland. Patients who used opioids were matched with Alzheimer’s patients who were not prescribed the drugs. The findings were published recently in the Journal of Alzheimer’s Disease. It is often difficult to assess pain among Alzheimer’s patients due to problems with communication, the researchers explained in a university news release. So if opioid painkillers […]
New insights into a specific gene variant may help to explain why some Alzheimer’s drugs work in certain people but may fail in others. The findings call for a more personalized approach to drug testing. An individual’s genotype may explain why some Alzheimer’s drugs work and others fail, new research shows. Earlier this year, a study led by Dr. Kinga Szigeti, Ph.D., who is the director of the Alzheimer’s Disease and Memory Disorders Center at the University of Buffalo, NY, found a key gene that helped explain why some Alzheimer’s drugs showed promise in animal models but failed in humans. The gene is called CHRFAM7A, and it is specific to humans, although only 75% of people have it. It is a so-called fusion gene — that is, a fusion between a gene that encodes a receptor for the neurotransmitter acetylcholine, and a type of enzyme called a kinase. Acetylcholine plays a key role in memory and learning, and researchers have long linked it with the development of Alzheimer’s. The CHRFAM7A fusion gene encodes the “[alpha]7 nicotinic acetylcholine receptor,” but because it only does so in humans, drugs targeting the alpha-7 receptor have proven successful in preclinical, animal models but not […]
New research has shown that impaired insulin signaling in the brain, often a feature of diabetes, may negatively impact cognition, mood, and metabolism — all of which are common aspects of Alzheimer’s disease. A new study examines the links between Alzheimer’s and diabetes. Although the conditions are seemingly independent of each other, earlier studies have found that people with type 2 diabetes are more likely to develop Alzheimer’s disease. However, the mechanisms behind this relationship have remained hidden. A recent study investigated the impact of blocking insulin receptors and insulin-like growth factor (IGF1) receptors in mouse models. The work was carried out at the Joslin Diabetes Center, affiliated with Harvard Medical School in Boston, MA. The results reveal that interrupting these similar pathways impaired both learning and memory. The researchers published their findings in the Proceedings of the National Academy of Sciences. Insulin receptors and learning The researchers worked with both the hippocampus and the central amygdala, areas of the brain that help with cognition function, as well as metabolic control. They looked into how mice with disabled insulin and IGF1 receptors tackled mazes, and the results were revealing. First, the researchers allowed the mice to explore the maze to […]
Memory can deteriorate naturally, due to age, and even when this process is not related to neurodegenerative conditions, such as Alzheimer’s, it can still affect a person’s quality of life. Now, researchers from Boston University in Massachusetts are exploring ways of fighting age-related memory decline. By resynchronizing brain waves, we could reverse some age-related memory problems. “Working memory […] is a fundamental building block of human cognition,” explains Robert Reinhart, Ph.D., the director of the university’s Visual Cognitive Neuroscience Laboratory. “It’s been called, classically, the ‘workbench of the mind’ or the ‘sketchpad of the mind.’ It allows us to hold information in our minds over a period of seconds,” he continues. Essentially, this is the type of memory that allows a person to make spontaneous calculations and assessments, and navigate daily life situations. But working memory also starts to naturally decline with age, which means that, as a person grows older, they may find it more difficult to perform some tasks, such as keeping track of their finances. “Working memory […] is where we think, where we problem-solve, where we reason, plan, perform mathematical calculations, make decisions. It’s essentially where consciousness lives.” Robert Reinhart, Ph.D. For this reason, Reinhart and […]
Latest Alzheimer’s News MONDAY, Aug. 12, 2019 (HealthDay News) — New research is untangling the complex relationship between symptoms of depression and losses in memory and thinking that often emerge together with Alzheimer’s disease. In fact, the new data suggests that “depression symptoms themselves may be among the early changes in the preclinical stages of dementia syndromes,” explained study lead author Dr. Jennifer Gatchel. She works in the division of geriatric psychiatry at Massachusetts General Hospital in Boston. In the study, researchers examined brain scans and other data gathered over seven years from 276 older adults enrolled in the Harvard Aging Brain Study. All of the participants were still living independently in the community at the beginning of the study and were considered healthy. However, the analysis revealed a significant link between worsening depression symptoms and mental decline over two to seven years, and both of these trends seemed to be linked to a buildup of amyloid protein in brain tissue. The slow accumulation of amyloid has long been known as a hallmark of Alzheimer’s disease. “Our research found that even modest levels of brain amyloid deposition can impact the relationship between depression symptoms and cognitive [thinking] abilities,” Gatchel said […]
Latest Alzheimer’s News MONDAY, Dec. 17, 2018 (HealthDay News) — Lots of Americans will unwrap a scarf or sweater this holiday season. But a growing number will receive a gift that’s potentially life-changing: an at-home genetic testing kit. Home DNA testing yields clues to ancestry and, potentially, genetic risk for medical conditions. But there are a number of things you need to know before you use one of these kits, the Alzheimer’s Foundation of America says. “Genetic testing kits are a popular gift, but the test results can have implications that last long after the holidays,” Lori Frank said in a foundation news release. She’s on the foundation’s medical, scientific and memory screening advisory board. “As with any health decision, consumers should have the right information before deciding to take a genetic test,” Frank said. Because genetic testing has potentially positive and negative impacts, the foundation offers some tips: Be informed. “Some people find the results upsetting and are concerned about the emotional impact to relatives with similar genetic risk, while others feel empowered to proactively take better care of their own health. It’s important to consider all impacts beforehand,” said Dr. J. Wesson Ashford, chair of the medical, scientific […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Staying active in old age may help preserve your memory and thinking skills, a new study suggests. In fact, older people who were physically active kept their minds sharp, even if their brains showed signs of lesions or other markers linked to Alzheimer’s disease or other dementias, researchers found. “Physical activity may provide cognitive reserve” that helps preserve the brain even in the face of dementia, said lead researcher Dr. Aron Buchman. He’s professor of neurology at Rush University Medical Center in Chicago. Lifestyle appears to play a major role in keeping the mind sharp as we age, he said. Other studies have found that keeping socially and mentally active also improves mental skills. “Together, these suggest that a more active lifestyle, including physical, cognitive and social activities, may help maintain cognition in older adults,” Buchman said. Buchman said he doesn’t know how these factors protect the brain, what kind of exercise is best, or how much is protective. Only an association was seen in the study, and more research is needed. “Even if we don’t have treatments for Alzheimer’s disease, there’s a benefit to having […]
For the first time, researchers have identified two clusters of genes that appear to generate the neurological hallmarks of dementia. The discovery provides a new path toward drug discovery. Understanding the genetic mechanisms behind Alzheimer’s moves us ever closer to an effective treatment. Dementia is a growing concern throughout the Western world and beyond. According to the Alzheimer’s Association, around 5.7 million adults in the United States are living with Alzheimer’s, the most common form of dementia. By 2050, that figure is expected to rise to about 14 million. As the average lifespan extends, so does the reach of dementia. Currently, there is no cure for dementia and no way to slow its progress. Although many questions about dementia remain unanswered, our understanding is steadily growing. For instance, we know that a protein called tau plays an important role in a number of dementia types. Tau and dementia In healthy nerve cells, tau helps stabilize microtubules — the scaffolding that helps maintain the structure and rigidity of cells. In dementia, however, tau becomes hyperphosphorylated and clumps together in so-called neurofibrillary tangles. Scientists think that when tau is tangled, it damages nerve cells in at least two ways. Firstly, it can […]
Alzheimer’s is a relentless disease in which toxic clusters of beta-amyloid protein collect in brain cells. Now, scientists have designed a synthetic peptide, or small protein, that can block beta-amyloid in its early and most harmful stages. New research may have found a way to stop Alzheimer’s-related brain damage in its early stages. The synthetic peptide, which has only 23 amino acids, folds into structures called alpha sheets. The sheets bind to early-stage, small clumps of beta-amyloid and stop them forming larger masses. A team from the University of Washington (UW) in Seattle and other research centers in the United States designed and produced the synthetic peptide and also tested it in cells and animals. The tests showed that alpha sheets of the peptide reduced the toxic impact of beta-amyloid in cultured human brain cells. The sheets also blocked early forms of beta-amyloid in animal models of Alzheimer’s disease. The Proceedings of the National Academy of Sciences is shortly to feature a paper about the study. The researchers say that the findings could lead to treatments that clear away toxic beta-amyloid in its early forms. They also see potential for using the peptide as the basis of a test for […]
By Serena GordonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, June 12, 2019 (HealthDay News) — Being yelled at or insulted is never easy. But it’s a situation faced by about one-quarter of U.S. home health care workers, a new study finds. Certain environments, such as caring for someone with dementia or working in a very cramped space, were linked to a higher risk of verbal abuse from patients or their kin. “Our study found that aides frequently experience verbal abuse from the clients and their families,” said the study’s senior author, Margaret Quinn. She’s director of the Safe Home Care Project at the University of Massachusetts, Lowell. “There is increasing scientific evidence that verbal abuse, as well as physical abuse, can have harmful, long-term impacts on employees’ health, such as depression and burnout, and on the stability of the workforce, such as high turnover, which is costly for employers and hard on those receiving care when an aide they’ve developed a relationship with does not return,” she said. Despite this study’s findings, Quinn said most home care aides report a high level of job satisfaction and get great reward from helping people age in place in their homes with dignity. Addressing […]
A new study in mice reveals that Candida albicans — a fungus largely perceived as harmless — can cause memory problems and brain abnormalities that resemble those characteristic of Alzheimer’s disease. C. albicans is the most common and best-studied cause of fungal infections in humans. Candida albicans is a species of fungus that grows naturally in the human gut, mouth, and vagina. Although the yeast is mostly harmless, it can develop into issues ranging from thrush to more serious infections that reach the blood and other organs. C. albicans is the most common cause of fungal infections in humans, as well as the most extensively studied fungal pathogen that affects people. A new study, which appears in the journal Nature Communications, adds to the existing body of knowledge about C. albicans. The new research shows that the fungus can enter the brain, trigger an inflammatory response, and impair memory in mice. Importantly, the infection leads to the formation of abnormal structures in the brain, and these share similarities with amyloid plaques — a hallmark of Alzheimer’s disease. Dr. David B. Corry, a professor of medicine-immunology, allergy, and rheumatology at the Baylor College of Medicine in Houston, TX, is the corresponding […]
Recent research reveals that leaky capillaries in the brain could have a role in the development of Alzheimer’s disease. Changes in blood vessel permeability offer new clues about the onset of dementia. Dementia, the main type of which is Alzheimer’s disease, affects about 50 million people worldwide. According to the Alzheimer’s Association, over 5 million people in the United States are living with Alzheimer’s. This number is expected to reach 14 million by 2050. For this reason, it is becoming more and more important to diagnose these health conditions earlier, and to locate new targets for drugs to slow down or prevent the condition. The Food and Drug Administration (FDA) have approved some drugs that help with the symptoms of Alzheimer’s disease, but none of them treat the underlying cause. A new study conducted at the University of Southern California (USC) in Los Angeles could pave the way for new, more effective treatments. The findings now appear in the journal Nature Medicine. Leaky capillaries in the brain Previous studies indicated that two toxic proteins, amyloid and tau, may be “the trigger and bullet” in the development of Alzheimer’s. Findings showed that soluble forms of amyloid and tau work together to […]
Researchers from the Massachusetts Institute of Technology have developed a machine-learning model that could predict the rate of Alzheimer’s-related cognitive decline for up to 2 years in the future. MIT researchers have developed a machine-learning model that they say could accurately predict cognitive decline. Alzheimer’s disease affects millions of people worldwide, yet scientists still do not know what causes it. For this reason, prevention strategies can be hit and miss. Moreover, healthcare professionals have no clear way of determining a person’s rate of cognitive decline once a doctor has diagnosed them with Alzheimer’s. Now, researchers from the Massachusetts Institute of Technology (MIT) in Cambridge — in collaboration with specialists from other institutions — have developed a machine-learning model that could allow specialists to predict how much a person’s cognitive functioning will change up to 2 years in advance of this decline becoming established. The team — made of Ognjen Rudovic, Yuria Utsumi, Kelly Peterson, Ricardo Guerrero, Daniel Rueckert, and Prof. Rosalind Picard — will present their project later this week at the Machine Learning for Healthcare conference. This year’s conference will take place in Ann Arbor, MI. “Accurate prediction of cognitive decline from 6 to 24 months is critical to […]
By Serena GordonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Feb. 6, 2019 (HealthDay News) — There are plenty of good reasons to seek a higher education, but avoiding Alzheimer’s disease probably isn’t one of them, new research suggests. The study found that a person’s level of education wasn’t related to the onset of memory and thinking (“cognitive”) troubles, or the rate at which dementia progressed. “Education is related to cognitive growth in early life, but it wasn’t associated with cognitive change as you age. What’s more important is what you’re doing now, than what you did 40 or 50 years ago,” explained study author Robert Wilson. He’s a neuropsychologist at Rush University Medical Center in Chicago. Wilson said that continuing to do things such as learning a new language, social activities, having a purpose in life, or engaging in mentally demanding work may help keep your brain sharper as you get older. Previous research has hinted that there might be a link between education and a person’s risk of developing dementia or Alzheimer’s disease, or how fast the disease advances. But the results of a number of studies looking at this possible link have had mixed results. To try to get […]
According to a team of Swedish-based researchers, breathing through the nose may help memory storage and consolidation. These findings are published in The Journal of Neuroscience. The way we breathe affects our memory in mysterious ways. Recently, neuroscientists have been scrutinizing the link between smell and memory. Some have suggested that a damaged sense of smell can predict dementia, and others have zoomed in on why that may be. Along the way to unraveling the Proustian mysteries of smells and memory, scientists have picked up several clues. The amygdala, which is a small brain region that processes sensory information, is close to the memory-storing hippocampus. Also, newer research shows that people with a good spatial memory may be better at identifying smells. Information related to time and space is present in the anterior olfactory nucleus, studies have shown. This is a brain area that is involved in the development of Alzheimer’s. New research now adds breathing into the mix. A study carried out by scientists at the Karolinska Institutet in Stockholm, Sweden, finds that breathing through the nose, rather than the mouth, improves olfactory memory. Artin Arshamian, a researcher at the Department of Clinical Neuroscience with the Karolinska Institutet, is […]
Latest Alzheimer’s News MONDAY, June 24, 2019 (HealthDay News) — Doctors often prescribe anticholinergic drugs for a variety of ills. But a new study suggests they may increase the risk of dementia in older patients. These medicines include everything from Benadryl (diphenhydramine) to certain antipsychotics and Parkinson’s meds. They’re used to treat a wide range of other conditions, including depression, chronic obstructive pulmonary disease, overactive bladder, allergies, and gastrointestinal disorders. Anticholinergic drugs help contract and relax muscles, and work by blocking acetylcholine, a chemical that transmits messages in the nervous system. But the new British study found that people aged 55 and older who took strong anticholinergic medications daily for three years or more had a 50% increased risk of dementia. “Our study adds further evidence of the potential risks associated with strong anticholinergic drugs, particularly antidepressants, bladder antimuscarinic drugs, anti-Parkinson drugs and epilepsy drugs,” said study author Carol Coupland. She works in the division of primary care at the University of Nottingham. Anticholinergics are known to cause short-term side effects — including confusion and memory loss — but it’s unclear if long-term use increases the risk of dementia. To find out, Coupland’s team examined the medical records of nearly […]
Latest Alzheimer’s News THURSDAY, Aug. 1, 2019 (HealthDay News) — A simple blood test helped pinpoint the early signs of Alzheimer’s in a new study. Up to two decades before people develop Alzheimer’s symptoms such as memory loss and confusion, harmful clumps of amyloid beta protein begin to accumulate in their brain, researchers explained. But it’s possible to measure levels of amyloid beta in the blood and use that information to determine whether the protein has accumulated in the brain, they added. Combining blood amyloid levels with two other major Alzheimer’s risk factors — age and the genetic variant APOE4 — can identify people who have early Alzheimer’s brain changes with 94% accuracy, according to the scientists from Washington University School of Medicine in St. Louis. The study included 150 adults over age 50 who had no thinking or memory problems. The blood test may be even more sensitive than the current gold standard — a PET brain scan — at detecting early amyloid accumulation in the brain, according to the authors. The findings advance efforts to have a blood test to identify people who will develop Alzheimer’s before they have symptoms, and such a test could be available in […]
A prescription drug already in use for the treatment of high blood pressure could be effective against conditions such as Parkinson’s, Alzheimer’s, and Huntington’s, in which toxic proteins build up in brain cells. Scientists could repurpose felodipine to prevent Parkinson’s disease. Scientists at the University of Cambridge in the United Kingdom and the Guangzhou Institutes of Biomedicine and Health in China suggest that the hypertension drug felodipine could be a promising candidate for “repurposing” as a treatment for neurodegenerative conditions. In experiments with zebrafish and mice, they showed that felodipine can prompt a cellular recycling process called autophagy to clear away toxic proteins in brain cells, or neurons. “Our data suggest,” they write in a recent Nature Communications paper, “that felodipine induces autophagy in neurons and enhances removal of a range of disease-causing proteins: mutant huntingtin, mutant [alpha]-synuclein, and tau.” Mutant huntingtin is characteristic of Huntington’s disease, while mutant alpha-synuclein and tau are hallmarks of Parkinson’s disease and Alzheimer’s disease, respectively. The study is important because it shows that felodipine can remove mutant alpha-synuclein from the brains of mice at blood levels “similar to those that would be seen in humans taking the drug [for hypertension].” “This is the first […]
For many years, specialists believed that people who studied more and kept their brains more active had lower dementia risk. Some recent studies have contradicted this idea. So how is education linked to the evolution of Alzheimer’s disease, if at all? Another study suggests that there is no link between a person’s level of education and Alzheimer’s-related cognitive decline. In the recent past, researchers have argued that people who continue their education throughout their lives have a lower risk of developing Alzheimer’s disease, which is the most common form of dementia and primarily characterized by progressive memory loss. However, studies published this year have found no evidence in support of this conclusion. A high level of education is supposed to boost a person’s cognitive reserve, which refers to the brain’s ability to preserve and maintain cognitive function despite any damage. A high cognitive reserve should act as a safeguard against cognitive impairment, which can occur naturally, as a person ages. But is it really effective in preventing or slowing down the development of Alzheimer’s disease? New research — conducted by Dr. Rebecca Gottesman, from The Johns Hopkins University School of Medicine, in Baltimore, MD, and colleagues — has found no […]
People with a diagnosis of dementia can also face depression. For this reason, they may end up taking antidepressant drugs. Now, a study has found that these drugs may be able to treat not just depression, but dementia itself. A new study tests out the potential of antidepressants to tackle dementia mechanisms in the brain. According to data cited by the Alzheimer’s Association, 1 in 10 people aged 65 and over has Alzheimer’s disease, a form of dementia, characterized chiefly by memory loss, disorientation, and having trouble with normal daily activities. Moreover, people with Alzheimer’s can often also develop mental health issues, especially depression. For this reason, healthcare professionals may prescribe selective serotonin reuptake inhibitors (SSRIs) — a class of antidepressants — to individuals with dementia. Recently, researchers from the University of Waterloo in Ontario, Canada, have found a surprising mechanism at play, namely that SSRIs appear to inhibit the growth of dementia-specific aggregates in the brain. “These are promising findings for people with Alzheimer’s who are on SSRIs,” notes Prof. Praveen Nekkar Rao, one of the current study’s authors. “These finding may not only highlight benefits for people with depression and Alzheimer’s but can also provide insights to serve […]
New research over a 28-year follow-up period finds significant evidence that frequent social contact at the age of 60 can lower the risk of developing dementia later on. Spending time with friends could stave off dementia for those 60 and older. The link between having a rich social life and brain health has received much attention in the scientific community. Some studies have suggested that levels of social interaction can predict cognitive decline and even dementia, while others have shown that group socializing can prevent the harmful effects of aging on memory. New research examines the link between social contact and dementia in more depth. Andrew Sommerlad, Ph.D., from the Division of Psychiatry at University College London (UCL), in the United Kingdom, is the first and corresponding author of the new study. Sommerlad and colleagues started from a critical observation of existing studies. They say that numerous findings have suggested that frequent social contact can protect the brain, either by helping to build a “cognitive reserve,” or by reducing stress and promoting more healthful behaviors. Many longitudinal studies have found an increased risk of dementia and cognitive decline in people with a smaller social network or less frequent social contact. […]
A protein that plays a key role in early neural development is also essential for learning and memory in the adult brain. A protein called netrin may boost learning and memory by strengthening neural connections in the adult brain. The protein, called netrin, strengthens connections between brain cells. This is according to recent research led by the Montreal Neurological Institute and Hospital (The Neuro), a teaching and research institute of McGill University in Canada. Scientists already knew that netrin is essential for the development of the embryonic and infant brain, where it helps make connections between brain cells, or neurons. The recent research reveals that the protein also strengthens those neural connections, or synapses, in the adult brain’s hippocampus, an area that is involved in memory and learning. The journal Cell Reports recently published a paper on the study, which the team conducted on cells from developing and adult rat brains. “It was a mystery,” comments senior study author Dr. Timothy E. Kennedy, who runs a research laboratory at The Neuro, “why neurons would continue making netrin in the adult brain after all the connections had already been made in infancy.” Molecule key for synapse strengthening According to Dr. Kennedy, […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News SUNDAY, May 5, 2019 (HealthDay News) — When men with prostate cancer have to take drugs that block the testosterone fueling their tumors, they can suffer a host of side effects that include impotence, bone loss, heart trouble and obesity. But new research uncovers yet another possible downside to the treatment: These men may be at greater risk for dementia. For any type of dementia, that risk increased 17%; for Alzheimer’s disease, it increased 23%, the researchers said. Common side effects of so-called androgen-deprivation therapy include hot flashes, unstable mood, trouble sleeping, headaches, high blood sugar, allergic reactions and impotence. “Androgen-deprivation therapy may not only cause physical changes — such as osteoporosis, cardiovascular disease or obesity — but may also cause changes in cognition,” said researcher Dr. Karl Tully, a research fellow at Brigham and Women’s Hospital in Boston. But Tully cautioned that this study cannot prove that such hormone therapy caused dementia, only that the two are associated. The investigators also found that men on this type of therapy had a 10% greater risk of seeking psychiatric services. The risk for dementia increased as the length of therapy increased, the researchers noted. […]
A new study finds that people with Alzheimer’s disease who also took antidiabetes medication exhibited fewer molecular markers of the neurological condition. These findings could inform future Alzheimer’s treatments. A study examined the molecular pathways of brain tissue and the cells that line the inside of blood vessels in the brains of people with Alzheimer’s and diabetes. New research — led by Vahram Haroutunian, Ph.D., a professor of psychiatry and neuroscience at the Icahn School of Medicine at Mount Sinai in New York City, NY — analyzed the brain tissues of people who had both Alzheimer’s disease and diabetes. The findings suggest that antidiabetes drugs may protect the brain against Alzheimer’s. As Prof. Haroutunian and colleagues explain in their paper, a mounting body of evidence has been pointing to a link between the risk of mild cognitive impairment, dementia, and type 2 diabetes. Additional studies have uncovered an association between an insulin receptor pathway in the brain and the accumulation of Alzheimer’s-specific brain pathologies. Previous studies conducted by the same Prof. Haroutunian and colleagues found that the brains of people with Alzheimer’s who had also undergone treatment for diabetes, such as insulin or antidiabetes medicine, had reduced brain pathologies. So, […]
A recent study concludes that social interaction might be more than just a pleasant pastime; it might help doctors predict an individual’s risk of cognitive decline and, perhaps, dementia. How does social interaction influence cognitive decline? Cognitive decline refers to a general reduction in mental abilities over time. It affects many people as they age and, in some cases, can lead to dementia. As the average age of the population rises, an increasing number of people are likely to experience cognitive decline. A group of researchers from Brigham and Women’s Hospital in Boston, MA, are interested in the potential role that social interaction might play. Specifically, their most recent study looked at whether there is an interaction between levels of social activity, cognitive performance, and the amount of beta-amyloid in the brain, which is a neurological hallmark of Alzheimer’s disease. Cognitive decline and sociability To investigate, the scientists followed 217 older adults involved in the Harvard Aging Brain Study. At the beginning of the study, participants were aged 63–89 and showed no cognitive deficits. The authors followed the group for 3 years. Each participant completed a questionnaire that ascertained their levels of social interaction; this included meeting family and friends, […]
In the future, a doctor might be able to tell whether someone is heading toward Alzheimer’s disease — not by carrying out expensive brain scans, but during an eye exam. One day, a simple eye test might help predict the onset of Alzheimer’s. A new study paper in the journal Ophthalmology Retina outlines research that took place at Duke Eye Center in Durham, NC. The researchers propose that a loss in density of blood vessels in the retina could suggest development of Alzheimer’s disease. Researchers studied more than 200 people with normal brain function as well as individuals with Alzheimer’s. They used a technique called optical coherence tomography angiography (OCTA), which is noninvasive and can reveal blood flow in every layer of the retina. In the control group, they found that the web of tiny blood vessels located at the back of the eye was quite dense. The vessels of those with Alzheimer’s disease, however, were less dense. In some cases, they were also much more sparse. Senior study author Dr. Sharon Fekrat, an ophthalmologist and retinal surgeon at Duke Eye Center, notes that they measured blood vessels that are not normally seen during a routine eye exam. She explains […]
Research showed that an antibiotic mix impacted the gut bacteria in mice to the point that it slowed the growth and development of Alzheimer’s, but only in males. New research in mice suggests that antibiotics may reduce Alzheimer’s symptoms by impacting the gut bacteria. The study, conducted at The University of Chicago, IL, demonstrated how long-term antibiotic use could reduce inflammation and slow the growth of amyloid plaques in male mice. Amyloid plaques are a feature specific to Alzheimer’s disease. They form when a particular protein within the neurons of the brain buildup and clump together. These amyloid plaques disrupt brain cell function and lead to the symptoms of Alzheimer’s. The team was led by Professor Sangram S. Sisodia, who is also the director of the Center for Molecular Neurobiology at The University of Chicago. The team was already aware that people with Alzheimer’s showed changes in their gut bacteria, and they had previously carried out studies showing how gut bacteria could potentially affect Alzheimer’s-like symptoms in rodents. This research found that changes to the microbiome limited the development of amyloid plaques in male mice, but not females. Sisodia says of the research that “[w]hile compelling, our published studies on […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News TUESDAY, Jan. 29, 2019 (HealthDay News) — Tight control of your blood pressure won’t necessarily spare you from full-blown dementia, a new trial concludes. But it might lower the risk of slight declines in thinking and memory, a condition known as mild cognitive impairment (MCI), the researchers added. The clinical trial is the “first study in history to show that any intervention can reduce your risk of developing mild cognitive impairment, an early form of dementia,” said lead researcher Dr. Jeff Williamson. He is a professor of gerontology and geriatric medicine at Wake Forest School of Medicine, in Winston-Salem, N.C. “What is good for your heart in terms of blood pressure-lowering is also good for your brain,” Williamson added. He noted that the trial ended early, which likely affected the dementia result. “We just didn’t have enough dementia cases develop over time” in the group with less-restricted blood pressure, he explained. High blood pressure affects more than three-fourths of people over the age of 65, and it has been identified as a potential risk factor for MCI and dementia in observational studies, the study authors said in background notes. The new clinical trial […]
An article, published in JAMA Network this month, attacks what it refers to as pseudomedicine. In particular, the authors are concerned that individuals with dementia and their families are being targeted. Is fear of dementia being used to sell pseudomedicine? Dementia is becoming increasingly prevalent as the population of the United States ages. Currently, 5.7 million people in the U.S. are living with Alzheimer’s, the most common form of dementia. Worldwide, an estimated 47 million individuals are living with dementia. However, to date, there is no cure, and treatments can only relieve certain symptoms for some people. Added to the millions who already have a dementia diagnosis, there are many millions more who are concerned that they, too, might develop dementia one day. A rise in quackery? All of these millions could, potentially, be vulnerable to anyone who claims to have answers, whether they offer improved treatments, preventative methods, or, indeed, cures. This perfect storm of growing prevalence and concern has, according to a recent article, sparked a steep rise in non-evidence-based treatments for dementia and general brain health. With today’s unparalleled access to information of all types, some individuals are being duped into investing in medical interventions that are […]
Dementia is a term that describes a variety of symptoms affecting a person’s cognitive functioning, including their ability to think, remember, and reason. It tends to get worse over time, so there are a few key early warning signs. Dementia occurs when nerve cells in a person’s brain stop working. Although it typically happens in older people, it is not an inevitable part of aging. The brain’s natural deterioration happens to everyone as they grow older, but it occurs more quickly in people with dementia. There are many different types of dementia. According to the National Institute on Aging, the most common is Alzheimer’s disease. Other types include: Lewy body dementia frontotemporal dementia vascular disorders mixed dementia, or a combination of types There are 10 typical early signs of dementia. For a person to receive a diagnosis, they would usually experience two or more of these symptoms, and the symptoms would be severe enough to interfere with their daily life. These early signs of dementia are: 1. Memory loss A person developing dementia may have trouble remembering dates or events. Memory loss is a common symptom of dementia. A person with dementia may find it difficult to recall information they […]
close
The information contained within this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Members contribute personal experiences by sharing what did or didn’t work to address their concern and help educate others which may expedite recovery. As such, always seek the advice of your physician or other qualified health provider with any questions about your medical condition. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Recent Comments